Description
Gemcitabine belongs to a group of medicines called cytotoxic agents. These drugs kill dividing cells, including cancer cells.
Indications
– Treatment of locally advanced or metastatic bladder cancer in combination with Cisplatin.
– Treatment of locally advanced or metastatic adenocarcinoma of the pancreas.
– In combination with Cisplatin it is indicated for first-line treatment of patients with locally advanced or metastatic non-small-cell lung carcinoma (NSCLC).
– Treatment of locally advanced or metastatic epithelial ovarian cancer in combination with Carboplatin in patients with relapsed disease after a remission of at least 6 months after first-line treatment of platinum-based.
– In combination with Paclitaxel it is indicated for treatment of patients with nonresectable locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy.
Subject to medical prescription
Pharmaceutical form: 200 mg powder for solution for infusion
Pharmaceutical form: 1000 mg powder for solution for infusion
